tamoghna mandal
BioClinicum, Karolinska University Hospital
Stockholm, Sweden
Review Editor
Anti-Cancer Drugs
Editors
- Frontiers in Drug Discovery
- Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
vincenzo marsicano
University of L'Aquila
L'Aquila, Italy
Review Editor
Anti-Cancer Drugs
victor mayoral-varo
Faculty HM Hospitals of Health Sciences, Camilo José Cela University
Madrid, Spain
Review Editor
Anti-Cancer Drugs
zukile mbita
University of Limpopo
Sovenga, South Africa
Review Editor
Anti-Cancer Drugs
dhanalekshmi meenakshi
National University of Sciences and Technology (NUST)
Islamabad, Pakistan
Review Editor
Anti-Cancer Drugs
carmen mejĂa
Autonomous University of Queretaro
Santiago de Querétaro, Mexico
Review Editor
Anti-Cancer Drugs
jiaqi mi
Boehringer Ingelheim
Ingelheim, Germany
Review Editor
Anti-Cancer Drugs
hongming miao
Army Medical University
Chongqing, China
Review Editor
Anti-Cancer Drugs
angelica montiel davalos
National Institute of Cancerology (INCAN)
Mexico City, Mexico
Review Editor
Anti-Cancer Drugs
andrew napper
Bristol Myers Squibb (United States)
New York, United States
Review Editor
Anti-Cancer Drugs
tian-miao ou
Sun Yat-sen University
Guangzhou, China
Review Editor
Anti-Cancer Drugs
teresita padilla-benavides
Wesleyan University
Middletown, United States
Review Editor
Anti-Cancer Drugs
pankaj pandey
University of Mississippi
Oxford, United States
Review Editor
Anti-Cancer Drugs
daniele passarella
University of Milan
Milan, Italy
Review Editor
Anti-Cancer Drugs
abraham pedroza-torres
ClĂnica de Cáncer Hereditario, Instituto Nacional de CancerologĂa.
Mexico City., Mexico
Review Editor
Anti-Cancer Drugs
eloy andres perez-yepez
National Institute of Cancerology (INCAN)
Mexico City, Mexico
Review Editor
Anti-Cancer Drugs